Period of time： 2014年6期
Publisher： Informa Healthcare
Founded in： 1991
Total resources： 179
ISSN： 1354-3776
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Therapeutic Patents,volume 15,issue 6
Menu
Hypoxia-activated anticancer drugs
Expert Opinion on Therapeutic Patents,volume 15,issue 6 , Vol. 15, Iss. 6, 2005-06 , pp.
Access to resources
Recommend
VEGF receptor kinase inhibitors: phthalazines, anthranilamides and related structures
By Dumas Jacques,Dixon Julie A in (2005)
Expert Opinion on Therapeutic Patents,volume 15,issue 6 , Vol. 15, Iss. 6, 2005-06 , pp.Ribonucleotide reductase: target therapy for human disease
By Gallicchio Vincent S in (2005)
Expert Opinion on Therapeutic Patents,volume 15,issue 6 , Vol. 15, Iss. 6, 2005-06 , pp.Cyclin-dependent kinase inhibitors: a survey of the recent patent literature
By Pevarello Paolo,Villa Manuela in (2005)
Expert Opinion on Therapeutic Patents,volume 15,issue 6 , Vol. 15, Iss. 6, 2005-06 , pp.Glucokinase: old enzyme, new target
By Kietzmann Thomas,Ganjam Goutham Kumar in (2005)
Expert Opinion on Therapeutic Patents,volume 15,issue 6 , Vol. 15, Iss. 6, 2005-06 , pp.